Milrinone inhibits hypoxia or hydrogen dioxide-induced persistent sodium current in ventricular myocytes

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 206-212

  Zheng, Jie ^a   Ma, Jihua ^a   Zhang, Peihua ^a   Hu, Liangkun ^a   Fan, Xinrong ^a   Tang, Qiong ^a  

^a WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hydrogen peroxide; Hypoxia; Milrinone; Patch clamp; Persistent sodium current

Indexed keywords

CYCLIC AMP; HYDROGEN PEROXIDE; MILRINONE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; TETRODOTOXIN;

ACTION POTENTIAL; ADULT ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GUINEA PIG; HEART MUSCLE CELL; HEART VENTRICLE; HYPOXIA; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; REPOLARIZATION; SODIUM CURRENT;

ACTION POTENTIALS; ANIMALS; CELL HYPOXIA; ELECTRIC CONDUCTIVITY; ENZYME INHIBITORS; FEMALE; GUINEA PIGS; HEART VENTRICLES; HYDROGEN PEROXIDE; ISOQUINOLINES; MALE; MILRINONE; MYOCYTES, CARDIAC; SODIUM; SULFONAMIDES;

EID: 67651122945     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.021     Document Type: Article

References (45)

1. Antzelevitch C. Electrical heterogeneity, cardiac arrhythmias, and the sodium channel. Circ. Res. 87 (2000) 964-965
2. Ashamalla S.M., Navarro D., and Ward C.A. Gradient of sodium current across the left ventricular wall of adult rat hearts. J. Physiol. 536 (2001) 439-443
3. Belardinellia L., Antzelevitch C., and Fraserc H. Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function. Eur. Heart J. 6 (2004) 13-17
4. Cesario D., Clark J., and Maisel A. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. Am. Heart J. 135 (1998) 121-129
5. Chen E.P., Bittner H.B., Davis Jr. R.D., and Van Trigt III P. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann. Thorac. Surg. 63 (1997) 814-821
6. Crotti L., Celano G., Dagradi F., and Schwartz P.J. Congenital long QT syndrome. Orphanet. J. Rare Dis. 3 (2008) 18
7. Cruickshank. Phosphodiesterase III inhibitors: long-term risks and short-term benefits. Cardiovasc. Drugs Ther. 7 (1993) 655-660
8. Farah A.E., and Frangakis C.J. Studies on the mechanism of action of the bipyridine milrinone on the heart. Basic Res. Cardiol. 84 (1989) 85-103
9. Friedman J.E., and Haddad G.G. Anoxia induces an increase in intracellular sodium in rat central neurons in vitro. Brain Res. 663 (1994) 329-334
10. Ju Y.K., Saint D.A., and Gage P.W. Hypoxia increases persistent sodium current in rat ventricular myocytes. J. Physiol. 497 (1996) 337-347
11. Haigney M.C., Lakatta E.G., Stern M.D., and Silverman H.S. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 90 (1994) 391-399
12. Hale S.L., and Kloner R.A. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. J. Cardiovasc. Pharmacol. Ther. 11 (2006) 249-255
13. Hoffman T.M., Wernovsky G., Atz A.M., Bailey J.M., Akbary A., Kocsis J.F., Nelson D.P., Chang A.C., Kulik T.J., Spray T.L., and Wessel D.L. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Am. Heart J. 143 (2002) 15-21
14. Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J., Nelson D.P., Chang A.C., Bailey J.M., Akbary A., Kocsis J.F., Kaczmarek R., Spray T.L., and Wessel D.L. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107 (2003) 996-1002
15. Honen B.N., and Saint D.A. Heterogeneity of the properties of INa in epicardial and endocardial cells of rat ventricle. Clin. Exp. Pharmacol. Physiol. 29 (2002) 161-166
16. Kiyosue T., and Arita M. Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes. Circ. Res. 64 (1989) 389-397
17. Kourie J.I. Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol. 275 (1998) 1-24
18. Levi A.J., Dalton G.R., Hancox J.C., Mitcheson J.S., Issberner J., Bates J.A., Evans S.J., Howarth F.C., Hobai I.A., and Jones J.V. Role of intracellular sodium overload in the genesis of cardiac arrhythmias. J. Cardiovasc. Electrophysiol. 8 (1997) 700-721
19. Ma J.H., Luo A.T., and Zhang P.H. Effect of hydrogen peroxide on persistent sodium current in guinea pig ventricular myocytes. Acta Pharmacol. Sin. 26 (2005) 828-834
20. Maltsev V.A., Silverman N., Sabbah H.N., and Undrovinas A.I. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur. J. Heart Fail. 9 (2007) 219-227
21. Marius-Nunez A.L., Heaney L., Fernandez R.N., Clark W.A., Ranganini A., Silber E., and Denes P. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am. Heart J. 132 (1996) 805-808
22. Marsh J.D., and Smith T.S. Calcium overload and ischemic myocardial injury. Circulation 83 (1991) 709-711
23. Niemann J.T., Garner D., Khaleeli E., and Lewis R.J. Milrinone facilitates resuscitation from cardiac arrest and attenuates postresuscitation myocardial dysfunction. Circulation 108 (2003) 3031-3035
24. Ono K., Kiyosue T., and Arita M. Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current. Am. J. Physiol. 256 (1989) 1131-1137
25. Saint D.A. The role of the persistent Na (+) current during cardiac ischemia and hypoxia. J. Cardiovasc. Electrophysiol. 17 (2006) S96-S103
26. Sakmann B.F., Spindler A.J., Bryant S.M., Linz K.W., and Noble D. Distribution of a persistent sodium current across the ventricular wall in guinea pigs. Circ. Res. 87 (2000) 910-914
27. Sasyniuk B.I., Valois M., and Toy W. Recent advances in understanding the mechanisms of drug-induced torsades de pointes arrhythmias. Am. J. Cardiol. 64 (1989) 29J-32J
28. Shaffer D., Singer S., Korvick J., and Honig P. Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System. Clin. Infect. Dis. 35 (2002) 197-200
29. Shimizu K., Shintani Y., Ding W.G., Matsuura H., and Bamba T. Potentiation of slow component of delayed rectifier K(+) current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G. Br. J. Pharmacol. 137 (2002) 127-137
30. Shipley J.B., Tolman D., Hastillo A., and Hess M.L. Milrinone: basic and clinical pharmacology and acute and chronic management. Am. J. Med. Sci. 311 (1996) 286-291
31. Simonton C.A., Chatterjee K., Cody R.J., Kubo S.H., Leonard D., Daly P., and Rutman H. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. J. Am. Coll. Cardiol. 6 (1985) 453-459
32. Song Y., Shryock J.C., and Luiz Belardinelli L. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H2031-H2039
33. Song Y., Shryock J.C., Wagner S., Maier L.S., and Belardinelli L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J. Pharmacol. Exp. Ther. 318 (2006) 214-222
34. Sossalla S., Wagner S., Rasenack E.C., Ruff H., Weber S.L., Schöndube F.A., Tirilomis T., Tenderich G., Hasenfuss G., Belardinelli L., and Maier L.S. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts - role of late sodium current and intracellular ion accumulation. J. Mol. Cell. Cardiol. 45 (2008) 32-43
35. Sugiyama A., and Hashimoto K. Can the MAP technique be applied to detect delayed afterdepolarization? Electrophysiologic and pharmacologic evidence. J. Cardiovasc. Pharmacol. 34 (1999) 46-52
36. Sutko J.L., Kenyon J.L., and Reeves J.P. Effects of amrinone and milrinone on calcium influx into the myocardium. Circulation 73 (1986) III52-III58
37. Thandroyen F.T., Morris A.C., Hagler H.K., Ziman B., Pai L., Willerson J.T., and Buja L.M. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ. Res. 69 (1991) 810-819
38. Uemura H., Sakamoto N., and Nakaya H. Electropharmacological effects of UK-1745, a novel cardiotonic drug, in guinea-pig ventricular myocytes. Eur. J. Pharmacol. 383 (1999) 361-371
39. Valdivia C.R., Chu W.W., Pu J., Foell J.D., Haworth R.A., Wolff M.R., Kamp T.J., and Makielski J.C. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J. Mol. Cell. Cardiol. 38 (2005) 475-483
40. Wang L., Lopaschuk G.D., and Clanachan A.S. H(2)O(2)-induced left ventricular dysfunction in isolated working rat hearts is independent of calcium accumulation. J. Mol. Cell. Cardiol. 45 (2008) 787-795
41. Ward C.A., and Giles W.R. Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J. Physiol. 500 (1997) 631-642
42. Wu L., Shryock J.C., Song Y., Li Y., Antzelevitch C., and Belardinelli L. Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome. J. Pharmacol. Exp. Ther. 310 (2004) 599-605
43. Yunomae K., Ichisaki S., Matsuo J., Nagayama S., Fukuzaki K., Nagata R., and Kito G. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity. J. Appl. Toxicol. 27 (2007) 78-85
44. Zabel M., Lichtlen P.R., Haverich A., and Franz M.R. Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart. J. Cardiovasc. Electrophysiol. 9 (1998) 1279-1284
45. Zygmunt A.C., Eddlestone G.T., Thomas G.P., Nesterenko V.V., and Antzelevitch C. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am. J. Physiol., Heart Circ. Physiol. 281 (2001) 689-697